| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8441648 | European Journal of Cancer | 2016 | 8 Pages |
Abstract
We demonstrate that statin use may be associated with improved survival in patients with mRCC treated in the targeted therapy era. Statins could represent an adjunct therapy for patients with mRCC; however, this is hypothesis generating and requires prospective evaluation.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Rana R. McKay, Xun Lin, Laurence Albiges, Andre P. Fay, Marina D. Kaymakcalan, Suzanne S. Mickey, Paiman P. Ghoroghchian, Rupal S. Bhatt, Samuel D. Kaffenberger, Ronit Simantov, Toni K. Choueiri, Daniel Y.C. Heng,